Rice bran extract supplement improves sleep efficiency and sleep onset in adults with sleep disturbance: A randomized, double-blind, placebo-controlled, polysomnographic study

被引:14
作者
Um, Min Young [1 ]
Yang, Hyejin [1 ]
Han, Jin Kyu [2 ]
Kim, Jin Young [3 ]
Kang, Seung Wan [3 ]
Yoon, Minseok [1 ]
Kwon, Sangoh [4 ]
Cho, Suengmok [5 ]
机构
[1] Korea Food Res Inst, Res Div Funct Food Functional, Wonju 55365, South Korea
[2] Seoul Sleep Ctr, Seoul 06041, South Korea
[3] Seoul Natl Univ, Dept Nursing, Seoul 03080, South Korea
[4] S&D Res & Dev Inst, Cheongju 28156, South Korea
[5] Pukyong Natl Univ, Dept Food Sci & Technol, Busan 48513, South Korea
关键词
QUALITY INDEX; INSOMNIA; EFFICACY; SAFETY; COMBINATION; PREVALENCE; ZOLPIDEM; SCALE; ACID;
D O I
10.1038/s41598-019-48743-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously reported that rice bran extract supplement (RBS) administration to mice decreased sleep latency and induced non-rapid eye movement (NREM) sleep via inhibition of the histamine H-1 receptor. Based on this, we performed the first clinical trial to investigate whether RBS would be beneficial to subjects with disturbed sleep. We performed a randomized, double-blinded, placebo-controlled, 2-week study. Fifty subjects with sleep disturbance were enrolled and received either RBS (1,000 mg/day) or placebo. Polysomnography was performed, and Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale (ESS), and Fatigue Severity Scale were administered at the initiation and termination of the study. Compared with the placebo, RBS led to significant polysomnographic changes, including decreased sleep latency (adjusted, P = 0.047), increased total sleep time (P = 0.019), and improved sleep efficiency (P = 0.010). Additionally, the amount of stage 2 sleep significantly increased in the RBS group. When adjusted for caffeine intake, wakefulness after sleep onset, total wake time, and delta activity tended to decrease in the RBS group. RBS administration decreased ESS scores. There were no reported serious adverse events in both groups. RBS improved sleep in adults with sleep disturbance. Trial registration: WHO ICTRP, KCT0001893.
引用
收藏
页数:8
相关论文
共 44 条
[1]  
[Anonymous], 2014, INV NAT OCC CAFF PLA
[2]  
[Anonymous], 2014, ASS CAFF INT FOODS
[3]   Vaterian for steep: A systematic re view and meta-anatysis [J].
Bent, Stephen ;
Padula, Amy ;
Moore, Dan ;
Patterson, Michael ;
Mehling, Woff .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) :1005-1012
[4]  
Bhat A, 2008, EXPERT OPIN PHARMACO, V9, P351, DOI [10.1517/14656566.9.3.351, 10.1517/14656566.9.3.351 ]
[5]  
Buysse D J, 1989, Psychiatry Res, V28, P193
[6]  
Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563
[7]  
Byun JI, 2018, J CLIN NEUROL, V14, P291
[8]   Sleep Deprivation and Divergent Toll-like Receptor-4 Activation of Cellular Inflammation in Aging [J].
Carroll, Judith E. ;
Carrillo, Carmen ;
Olmstead, Richard ;
Witarama, Tuff ;
Breen, Elizabeth C. ;
Yokomizo, Megumi ;
Seeman, Teresa E. ;
Irwin, Michael R. .
SLEEP, 2015, 38 (02) :205-211
[9]   Epidemiology of Insomnia in Korean Adults: Prevalence and Associated Factors [J].
Cho, Yong Won ;
Shin, Won Chul ;
Yun, Chang Ho ;
Hong, Seung Bong ;
Kim, Juhan ;
Earley, Christopher J. .
JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (01) :20-23
[10]   The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia [J].
Coleman, Paul J. ;
Gotter, Anthony L. ;
Herring, W. Joseph ;
Winrow, Christopher J. ;
Renger, John J. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 :509-533